IRIX
NASDAQ
Health Care
$0.93
USD
-$0.01 (-0.94%)
At close: Jul 20, 2026, 4:00 PM EDT
Market Cap:
$15.98M
Volume:
57.6K
Previous Close
$0.93
Day Range
$0.92 - $0.94
52 Week Range
$0.87 - $1.65
Average Volume (10 Days)
60.0K
P/E Ratio (TTM)
—
Dividend Yield
—
IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is headquartered in Mountain View, California and currently employs 93 full-time employees. The firm is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
CEO
Mr. Patrick Mercer
Headquaters
Mountain View, CALIFORNIA, US
Founded
1996
Employees
93